Related Experiment Video
Updated: Nov 5, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase
Wenzhang Liang1,2,3, Yue Zhang1,2, Miao Li1,2
1Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.
Insights
Cyclophilin A (cypA) inhibits human respiratory syncytial virus (hRSV) replication by interacting with the viral N protein. This interaction, dependent on cypA
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Human respiratory syncytial virus (hRSV) is a major cause of infant acute lower respiratory infection (ALRI).
- Understanding virus-host interactions is crucial for developing effective antiviral strategies against hRSV.
- Cyclophilin A (cypA) is a host protein whose role in hRSV infection requires further elucidation.
Purpose of the Study:
- To investigate the role of cyclophilin A (cypA) in human respiratory syncytial virus (hRSV) replication.
- To determine the mechanism by which cypA influences hRSV proliferation.
- To identify specific viral components that interact with cypA during infection.
Main Methods:
- Expression analysis of cypA in hRSV-infected patients, mice, and epithelial cells.
- Functional assays using cypA knockdown and overexpression in host cells to assess viral replication.
- Liquid chromatography-mass spectrometry (LC-MS) to identify cypA-interacting viral proteins.
- Co-immunoprecipitation and immunofluorescence assays to confirm cypA-RSV N protein interaction.
Main Results:
- hRSV infection significantly upregulated cypA expression in clinical samples, animal models, and cell cultures.
- Reduced cypA levels enhanced hRSV replication, while increased cypA levels inhibited it.
- cypA's inhibitory effect on hRSV replication was dependent on its peptidyl-prolyl cis-trans isomerase (PPIase) activity.
- cypA was found to interact with multiple hRSV proteins, including RSV-N, RSV-P, and RSV-M2-1, with a specific interaction confirmed between cypA and RSV-N.
Conclusions:
- Cyclophilin A (cypA) plays an inhibitory role in human respiratory syncytial virus (hRSV) replication.
- cypA interacts with the viral nucleoprotein (RSV-N) via its PPIase activity, potentially impairing viral RNP complex formation and function.
- These findings offer novel insights into cypA's antiviral mechanisms and suggest potential therapeutic targets for hRSV infection.
Abstract:
Human respiratory syncytial virus (hRSV) is the most common pathogen which causes acute lower respiratory infection (ALRI) in infants. Recently, virus-host interaction has become a hot spot of virus-related research, and it needs to be further elaborated for RSV infection. In this study, we found that RSV infection significantly increased the expression of cyclophilin A (cypA) in clinical patients, mice, and epithelial cells. Therefore, we evaluated the function of cypA in RSV replication and demonstrated that virus proliferation was accelerated in cypA knockdown host cells but restrained in cypA-overexpressing host cells. Furthermore, we proved that cypA limited RSV replication depending on its PPIase activity. Moreover, we performed liquid chromatography-mass spectrometry, and the results showed that cypA could interact with several viral proteins, such as RSV-N, RSV-P, and RSV-M2-1. Finally, the interaction between cypA and RSV-N was certified by coimmunoprecipitation and immunofluorescence. Those results provided strong evidence that cypA may play an inhibitory role in RSV replication through interaction with RSV-N via its PPIase activity. IMPORTANCE RSV-N, packed in the viral genome to form the ribonucleoprotein (RNP) complex, which is recognized by the RSV RNA-dependent RNA polymerase (RdRp) complex to initiate viral replication and transcription, plays an indispensable role in the viral biosynthesis process. cypA, binding to RSV-N, may impair this function by weakening the interaction between RSV-N and RSV-P, thus leading to decreased viral production. Our research provides novel insight into cypA antiviral function, including binding to viral capsid protein to inhibit viral replication, which may be helpful for new antiviral drug exploration.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
09:08Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
Published on: July 27, 2021
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
GPCRs Regulate Adenylyl Cylase Activity
Viruses with RNA Genomes
Retrovirus Life Cycles
Leaky Scanning